Jane Street
DNA icon

Jane Street’s Ginkgo Bioworks DNA Stock Holding History

Jane Street’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,018
Closed -$175K – 11854
2025
Q4 		$175K Sell
21,018
-84,092
-80% -$906K ﹤0.01% 9836
2025
Q3 		$1.53M Buy
105,110
+29,810
+40% +$357K ﹤0.01% 5433
2025
Q2 		$847K Buy
75,300
+39,200
+109% +$304K ﹤0.01% 5934
2025
Q1 		$206K Sell
36,100
-4,024
-10% -$41K ﹤0.01% 8406
2024
Q4 		$394K Sell
40,124
-52,066
-56% -$446K ﹤0.01% 7256
2024
Q3 		$751K Buy
92,190
+77,722
+537% +$779K ﹤0.01% 6463
2024
Q2 		$193K Sell
14,468
-910
-6% -$27.2K ﹤0.01% 8410
2024
Q1 		$714K Sell
15,378
-5,307
-26% -$275K ﹤0.01% 6048
2023
Q4 		$1.4M Buy
20,685
+13,500
+188% +$827K ﹤0.01% 4943
2023
Q3 		$520K Buy
7,185
+490
+7% +$39.2K ﹤0.01% 6241
2023
Q2 		$498K Sell
6,695
-2,845
-30% -$168K ﹤0.01% 6327
2023
Q1 		$508K Sell
9,540
-8,801
-48% -$558K ﹤0.01% 6290
2022
Q4 		$1.24M Sell
18,341
-1,994
-10% -$183K ﹤0.01% 4626
2022
Q3 		$2.54M Buy
20,335
+13,542
+199% +$1.61M ﹤0.01% 3766
2022
Q2 		$647K Sell
6,793
-6,085
-47% -$742K ﹤0.01% 6271
2022
Q1 		$2.08M Sell
12,878
-4,450
-26% -$866K ﹤0.01% 4692
2021
Q4 		$5.76M Buy
17,328
+7,978
+85% +$3.79M ﹤0.01% 2639
2021
Q3 		$4.33M Buy
+9,350
New +$4.55M ﹤0.01% 2974

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's DNA Position: Q1 2026 in Review

Jane Street sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 181,755 shares — an estimated $1.51M sold.

Jane Street first reported a position in DNA in Q3 2021 and held it in 15 quarters. The position peaked at $6.17M in Q4 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Jane Street reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 181,755 Ginkgo Bioworks shares in Q1 2026, an estimated $1.51M.
  • Jane Street first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 15 quarters.
  • Jane Street's Ginkgo Bioworks position peaked at $6.17M in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.